Vol. 62, Issue 2, 289-296, August 2002

Inhibition of Branched-Chain -Keto Acid Dehydrogenase Kinase and Sln1 Yeast Histidine Kinase by the Antifungal Antibiotic Radicicol

Paul G. Besant,¹ Michael V. Lasker, Cuong D. Bui, and Christoph W. Turck²

Department of Medicine (P.G.B., C.W.T.), Howard Hughes Medical Institute (M.V.L., C.D.B., C.W.T.), and Cardiovascular Research Institute (C.W.T.), University of California, San Francisco

The 90-kDa heat shock family (HSP90) of protein and two-component histidine kinases, although quite distinct at the primary amino acid sequence level, share a common structural ATP-binding domain known as the Bergerat fold. The Bergerat fold is important for the ATPase activity and associated chaperone function of HSP90. Two-component histidine kinases occur in bacteria, yeast, and plants but have yet to be identified in mammalian cells. The antifungal antibiotic radicicol (Monorden) has been shown to bind to the Bergerat fold of HSP90 and to inhibit its ATPase activity. The structural similarity between the Bergerat fold of HSP90 and bacterial two-component histidine kinases prompted our inquiry into whether radicicol could be a potential inhibitor of histidine kinase-like proteins. Structural homology searches suggest that the ATP-binding domains of the yeast histidine kinase Sln1 and the mammalian, branched-chain -keto acid dehydrogenase kinase are very similar to that of other Bergerat fold family members. On the basis of structural homology, we tested radicicol as a potential inhibitor of Sln1 and branched-chain -keto acid dehydrogenase kinase (BCKDHK) and propose a mechanism of inhibition of these kinases. Although BCKDHK has been shown to have serine autophosphorylation activity, we speculate, based on the results from this study and other supporting evidence, that BCKDHK may also have intrinsic histidine kinase activity.